Search global stocks & ETFs...Ctrl K
Learn Mode
Indivior Pharmaceuticals, IncINDV
$38.30
$0.37 (0.975%)
$38.25
-$0.05 (-0.128%)
INDV
Stock Profile
07-29
Recommended Metric
Score Card
Explore Scores Tab
3.25
Average
Valuation Score
Key Score
5.00
Very Good
Management
4.00
Good
Growth
3.00
Average
Profitability
5.00
Very Good
Fin. Health
2.00
Bad
Dividends
--
--
Analyst
5.00
Very Good
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$38.30
Baseline
High
$61.95
▲
61.75%
Avg
$50.83
▲
32.72%
Low
$42.42
▲
10.76%
Analyst Ratings based on 12 Analysts
Strong Buy
433%
Buy
758%
Hold
108%
Sell
000%
Strong Sell
000%
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The firm provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The company sells its products in the United States and in other selected areas of the world.Read More